logo

For the Inventor, By the Inventor

Waltham, MA, United States of America

Translate Bio, Inc.


USPTO Granted Patents = 174

% Expired Patents = 0.57



Trademarks = 1

Forward Citations = 584

Loading Chart...
Loading Chart...

70 inventors (with patents filed for the assignee):

goldMedal Michael W Heartlein (139 out of 188 patents)

silverMedal Frank DeRosa (132 out of 146 patents)

bronzeMedal Shrirang Karve (65 out of 70 patents)

4.  Braydon Charles Guild (45 out of 61 patents)

5.  Anusha Dias (38 out of 39 patents)

6.  Frank Derosa (23 out of 27 patents)

7.  Jonathan Abysalh (13 out of 13 patents)

8.  Arthur Mertz Krieg (13 out of 69 patents)

9.  Romesh R Subramanian (12 out of 77 patents)

10.  Zarna Patel (11 out of 14 patents)

11.  Lianne Smith (11 out of 13 patents)

12.  Ashish Sarode (8 out of 11 patents)

13.  Daniel Crawford (8 out of 9 patents)

14.  Yi Zhang (8 out of 8 patents)

15.  Jeannie T Lee (6 out of 28 patents)


Core Competencies:
Messenger RNA
Lipid Nanoparticles
Cationic Lipids
Purification Methods
mRNA Therapy
Nucleic Acids
Codon-Optimized
Biodegradable Lipids
Nanoparticle Formulations
Cystic Fibrosis
Genetic Disorders
Enzyme Modification

174 patents:

1. 12747198 - Phenolic acid lipid based cationic lipids (2026-09-29),
2. 12746203 - Pumpless encapsulation of messenger RNA (2026-09-29),
3. 12702693 - TREATMENT OF CYSTIC FIBROSIS BY DELIVERY OF CODON-OPTIMIZED mRNA ENCODING CFTR (2026-08-11),
4. 12698258 - Cystine cationic lipids (2026-08-04),
5. 12697309 - MRNA-loaded lipid nanoparticles and processes of making the same (2026-08-04),
6. 12697302 - Tricine and citric acid lipids (2026-08-04),
7. 12678406 - Process of preparing ice-based lipid nanoparticles (2026-07-14),
8. 12673086 - Process and formulation of lipid nanoparticles (2026-07-07),
9. 12655095 - TES-based cationic lipids (2026-06-16),
10. 12600998 - Large Scale Synthesis of Messenger RNA (2026-04-14),
11. 12594295 - CFTR MRNA COMPOSITIONS AND RELATED METHODS AND USES (2026-04-07),
12. 12594245 - Dry Powder Formulations for Messenger RNA (2026-04-07),
13. 12577600 - MODIFICATION OF RNA-RELATED ENZYMES FOR ENHANCED PRODUCTION (2026-03-17),
14. 12577554 - Methods for Purification of Messenger RNA (2026-03-17),
15. 12576030 - COMPOSITIONS FOR DELIVERY OF CODON-OPTIMIZED MRNA (2026-03-17),
Company Overview
Translate Bio, Inc., based in Waltham, MA, specializes in messenger RNA (mRNA) delivery technologies. The company focuses on developing innovative therapies utilizing lipid nanoparticles and cationic lipids for effective mRNA delivery. Their core research encompasses purification methods and the optimization of nucleic acids, aiming to advance mRNA therapy applications. Translate Bio is dedicated to harnessing the potential of biodegradable lipids to enhance therapeutic outcomes in various medical fields.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 6 2026

174 Patents

#11 in Waltham, MA

#126 in Massachusetts

#2,308 in US

#4,767 in the World

Waltham, MA (US)
Waltham, MA, United States of America

Translate Bio, Inc.

Forward Citations = 584

70 inventors:

goldMedal Michael W Heartlein (139 out of 188 patents)

silverMedal Frank DeRosa (132 out of 146 patents)

bronzeMedal Shrirang Karve (65 out of 70 patents)

4.  Braydon Charles Guild (45 out of 61 patents)

5.  Anusha Dias (38 out of 39 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Translate Bio, Inc.. Retrieved from https://idiyas.com/company/translate-bio

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…